Ascendis Pharma A (ASND) Common Equity (2012 - 2026)
Ascendis Pharma A's Common Equity came in at $1.67 billion for the quarter ended Jun 30, 2026, compared with -$212.32 million a year earlier and up 192.3% from the prior quarter.
Ascendis Pharma A (ASND) Common Equity (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Ascendis Pharma A's Common Equity was -$183.96 million.
- Going back by year, Common Equity was -$114.41 million in the year ended Dec 31, 2024, -$157.6 million in the year ended Dec 31, 2023, $277.56 million in the year ended Dec 31, 2022 (-72.5%) and $1.01 billion in the year ended Dec 31, 2021 (+1.1%).
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Common Equity in data going back to the quarter ended Dec 31, 2012.
- The fastest year-over-year change in Common Equity over five years came in the quarter ended Sep 30, 2021 (growth of 5.4%), and the weakest in the quarter ended Jun 30, 2023 (a decline of 89.1%).
- Business Quant data shows ASND's Common Equity at $571.29 million (quarter ended Mar 31, 2026), -$189.53 million (quarter ended Dec 31, 2025) and -$203.5 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.42 Bn | 1,106.00 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 617.98 Bn | 536.51 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 502.80 Bn | 475.92 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 368.67 Bn | 323.05 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.36 Bn | 262.35 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.17 Bn | 234.85 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.18 Bn | 192.58 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.11 Bn | 165.31 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Ascendis Pharma A | 14.45 Bn | 10.71 Bn | 362.22 Mn | 1.64 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Bn |
| Mar 31, 2026 | 559.22 Mn |
| Dec 31, 2025 | -191.27 Mn |
| Sep 30, 2025 | -204.24 Mn |
| Jun 30, 2025 | -219.97 Mn |
| Mar 31, 2025 | -205.45 Mn |
| Dec 31, 2024 | -110.00 Mn |
| Sep 30, 2024 | -108.70 Mn |
| Jun 30, 2024 | -343.88 Mn |
| Mar 31, 2024 | -257.10 Mn |
| Dec 31, 2023 | -161.26 Mn |
| Sep 30, 2023 | -77.56 Mn |
| Jun 30, 2023 | 70.47 Mn |
| Mar 31, 2023 | 182.33 Mn |
| Dec 31, 2022 | 280.75 Mn |
| Sep 30, 2022 | 443.86 Mn |
| Jun 30, 2022 | 634.99 Mn |
| Mar 31, 2022 | 750.99 Mn |
| Dec 31, 2021 | 1.00 Bn |
| Sep 30, 2021 | 1.15 Bn |
Ascendis Pharma A Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ASND&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();